Royal Caribbean Cruises Ltd.RCL
NYSE • Consumer Cyclical
$276.67
P/E
17.77
PEG
—
FCF Yield
—
Rev Growth YoY
+880.0% YoY
Gross Margin
5062.0%
Health Score
4/10
D/E Ratio
2.13
Confidence
LOW
Business Snapshot
Royal Caribbean Cruises Ltd. is one of the world's largest cruise operators, running a portfolio of global brands that serve millions of passengers annually across ocean and river cruise itineraries. The company operates in the highly cyclical leisure travel sector, competing on fleet capacity, onboard experience, and destination breadth. Based on available price and ratio data, RCL sits in the large-cap tier by any reasonable estimate given its scale and exchange listing, though a precise market cap figure is unavailable from the current data payload.
Financial Health
**Score: 4/10** RCL's financial health presents a sharply mixed picture. On one hand, reported gross margin stands at an extraordinary 5,062% and net margin at 2,380% — figures so anomalous they almost certainly reflect base-period distortions from pandemic-era near-zero revenues rather than sustainable operating reality, and should be interpreted with extreme caution...
Risk Assessment
- **DEBT:** Debt/Equity of 2.13x indicates a highly leveraged balance sheet, amplifying downside risk in any revenue slowdown or rising interest rate environment. - **VALUATION CONTRADICTION:** P/E of 17.77x appears cheap relative to the 25x sector average, but EV/EBITDA of 77.22x is extremely elevated — these signals conflict and suggest earnings quality or capital structure distortions. - **CASH FLOW:** Free cash flow data is entirely unavailable, making it impossible to verify whether reported earnings translate into real cash generation to service a 2.13x Debt/Equity load. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA), bearish MACD signal, and a current price of $276.67 sitting 24.5% below its 52-week high of $366.50 indicate meaningful near-term technical weakness. - **BASE EFFECT DISTORTION:** Revenue growth of 880% YoY and margins in the thousands of percent are pandemic-recovery artefacts, not repeatable performance — forward comparisons will normalise sharply lower, risking growth disappointment. ---...